A trial fibrillation (AF) is the most common sustained arrhythmia and is associated with significant morbidity, mortality, and cost (1,2).AF results from the occurrence of 3 mechanisms (3,4): 1) single-circuit re-entry; 2) multiple circuit reentry; or 3) rapid focal ectopic activity. Maintenance of AF requires that an appropriate substrate exist on which a trigger can initiate re-entry. The substrate for AF consists of 2 components: 1) altered electrophysiological properties; and 2) altered structural properties of the atrium. Uncontrolled hypertension can result in several changes to the left atrial substrate including effects on ion channel function and increased atrial fibrosis (Figure 1) (5-7).Despite advancements in ablation technologies over the past decade, including contact force technology and the second-generation cryoballoon, the recurrence rate of AF after catheter ablation remains high (8-10). These observations have led those of us who treat AF to examine other contributors to AF, with the realization that ablation alone may be insufficient to result in optimal arrhythmia control in patients. Hypertension is an obvious target given that is the most prevalent and potentially modifiable risk factor for AF (11,12). Multiple animal and clinical human studies have found a direct relationship between the risk of AF and systolic and diastolic blood pressure (13)(14)(15)(16)(17)(18)(19)(20). In this issue of JACC: Clinical Electrophysiology, Santoro et al. (21) report results of a carefully conducted prospective cohort study of 531 consecutive patients who underwent ablation for AF grouped by uncontrolled hypertension (n ¼ 160), controlled hypertension (n ¼ 192), or no hypertension (n ¼ 179). All patients underwent pulmonary vein (PV) antral isolation with additional ablation performed for non-PV triggers, as determined by operator discretion. The main findings of this study were that uncontrolled hypertension, as measured before the procedure, was associated with a significantly increased risk of recurrence (40.6%) at a follow-up of 19 AE 7.7 months after a single ablation procedure compared with those patients who had controlled hypertension (28.1%) or no hypertension (25.7%). The presence of non-PV triggers was greater (58.8% vs. 33.3%) in the group with uncontrolled hypertension.Ablation of non-PV triggers was associated with a significant reduction in AF recurrence compared with those whose non-PV triggers were left alone (69.8% vs. 37.3%).This study is certainly compelling in advancing the notion that blood pressure control is indeed exquisitely linked to recurrence of AF after catheter ablation. There are, however, important caveats to this study that prevent this trial from being definitive.The lack of randomization is an obvious limitation of the study, recognized by the authors. Most importantly, this study did not address the effect of aggressive blood pressure control and its interaction with outcomes of catheter ablation. This is a key question that needs to be addressed in order to assess how ...